Saturday, July 11, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “vaccine”

821 pharma patents match "vaccine" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 821
Index total 30,257
Page 27 / 35

Quick answer

This filtered view shows 821 pharmaceutical patents matching "vaccine" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

821 results for “vaccine” · 30,257 patents in full index Clear search

  1. US 7638333

    Anthrax vaccine

    The United States of America as represented by the Secretary of the Army · Granted Dec 29, 2009 · Expires Dec 24, 2029

    granted

  2. US 7638130

    Truncated recombinant major outer membrane protein antigen (R56) of Orientia tsutsugamushi strains Karp, Kato and Gilliam and its use in antibody based detection assays and vaccines

    United States of America as represented by the Secretary of the Air Force · Granted Dec 29, 2009 · Expires Dec 24, 2029

    granted

  3. US 7635483

    Streptococcal C5a peptidase vaccine

    Regents of the University of Minnesota · Granted Dec 22, 2009 · Expires Dec 17, 2029

    granted

  4. US 7635688

    Development of a preventive vaccine for filovirus infection in primates

    The United States of America, as represented by the Department of Health and Human Services · Granted Dec 22, 2009 · Expires Dec 17, 2029

    granted

  5. US 7632508

    Attenuated human-bovine chimeric parainfluenza virus (PIV) vaccines

    The United States of America · Granted Dec 15, 2009 · Expires Dec 10, 2029

    granted

  6. US 7625571

    Transformed bacteria producing CS6 antigens as vaccines

    The United States of America as represented by the Secretary of the Army · Granted Dec 1, 2009 · Expires Nov 26, 2029

    granted

  7. US 7622123

    Attenuated human-bovine chimeric parainfluenza virus (PIV) vaccines

    The United States of America, as represented by the Department of Health and Human Services · Granted Nov 24, 2009 · Expires Nov 19, 2029

    granted

  8. US 7608268

    Ferritin fusion proteins for use in vaccines and other applications

    New Century Pharmaceuticals, Inc. · Granted Oct 27, 2009 · Expires Oct 22, 2029

    granted

  9. US 7604811

    Oral-intestinal vaccines against diseases caused by enteropathic organisms using antigens encapsulated within biodegradable-biocompatible microspheres

    The United States of America as represented by the Secretary of the Army · Granted Oct 20, 2009 · Expires Oct 15, 2029

    granted

  10. US 7595191

    Isolation and purification of P. falciparum merozoite protein-142 vaccine

    The United States of America as represented by the Secretary of the Army · Granted Sep 29, 2009 · Expires Sep 24, 2029

    granted

  11. US 7572891

    Kidney-specific tumor vaccine directed against kidney tumor antigen G-250

    The Regents of the University of California · Granted Aug 11, 2009 · Expires Aug 6, 2029

    granted

  12. US 7572449

    Vaccine against Yersinia comprising one or two antibodies, one specific for Yersinia pestis F1-antigen and the other one for Yersinia pestis V-antigen

    The Secretary of State for Defence in Her Britannic Majesty's Government of the United Kingdom of Great Britain and Northern Ireland · Granted Aug 11, 2009 · Expires Aug 6, 2029

    granted

  13. US 7563883

    Recombinant P. falciparum merozoite protein-142 vaccine

    The United States of America as represented by the Secretary of the Army · Granted Jul 21, 2009 · Expires Jul 16, 2029

    granted

  14. US 7553490

    Vaccines against Escherichia coli O157 infection

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Jun 30, 2009 · Expires Jun 25, 2029

    granted

  15. US 7541043

    Vaccine for protection against Shigella sonnei disease

    The United States of America, as represented by the Department of Health and Human Services · Granted Jun 2, 2009 · Expires May 28, 2029

    granted

  16. US 7538183

    HPV vaccine comprising peptides from host cell proteins

    University College Cardiff Consultants Limited · Granted May 26, 2009 · Expires May 21, 2029

    granted

  17. US 7527802

    Vaccine for transcutaneous immunization

    The United States of America as represented by the Secretary of the Army · Granted May 5, 2009 · Expires Apr 30, 2029

    granted

  18. US 7527797

    Vibrio cholerae 0139 conjugate vaccines

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted May 5, 2009 · Expires Apr 30, 2029

    granted

  19. US 7517531

    Dengue tetravalent vaccine containing a common 30 nucleotide deletion in the 3′-UTR of dengue types 1,2,3, and 4, or antigenic chimeric dengue viruses 1,2,3, and 4

    The United States of America, as represented by the Department of Health and Human Services · Granted Apr 14, 2009 · Expires Apr 9, 2029

    granted

  20. US 7514529

    Peptide mimotopes of lipooligosaccharide from nontypeable Haemophilus influenzae as vaccines

    The United States of America, as represented by the Department of Health and Human Services · Granted Apr 7, 2009 · Expires Apr 2, 2029

    granted

  21. US 7485415

    Sequence analysis of the tetravalent rotavirus vaccine

    The United States of America, as represented by the Department of Health and Human Services · Granted Feb 3, 2009 · Expires Jan 29, 2029

    granted

  22. US 7485440

    Production of attenuated respiratory syncytial virus vaccines involving modification of M2 ORF2

    The United States of America, as represented by the Department of Health and Human Services · Granted Feb 3, 2009 · Expires Jan 29, 2029

    granted

  23. US 7479550

    Amyloid β gene vaccines

    The Board of Regents of the University of Texas System · Granted Jan 20, 2009 · Expires Jan 15, 2029

    granted

  24. US 7431929

    Use of vaccinia virus deleted for the E3L gene as a vaccine vector

    THE ARIZONA BOARD OF REGENTS · Granted Oct 7, 2008 · Expires Oct 2, 2028

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.